Company family
Eql: medicine shortages
As of 2 Nov 2026, 31 Eql products have a reported shortage across 1 countries, covering 9 medicines.
Products short31rank #68 of 464
Medicines9active ingredients
Countries1/16
New in 90 days5+5 vs market pace
Typical duration9 monthsmedian so far
Manufacturing0%demand-driven 0%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Phenoxymethylpenicillin | 19 | 1 Jan 2023 | Not stated | 5/16 | |
| Flucloxacillin | 3 | 1 Feb 2026 | Not stated | 2/16 | |
| Potassium Chloride | 2 | 15 Nov 2026 | Not stated | 5/16 | |
| Tobramycin | 2 | 1 Mar 2026 | Not stated | 5/16 | |
| Bupivacaine | 1 | 1 Aug 2024 | Not stated | 8/16 | |
| Ketorolac | 1 | 1 Aug 2024 | Not stated | 4/16 | |
| Levosimendan | 1 | 7 Aug 2024 | Not stated | 4/16 | |
| Ondansetron | 1 | 19 Aug 2024 | Not stated | 9/16 | |
| Paracetamol | 1 | 1 Jul 2023 | Not stated | 10/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.